Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

NCT00828841 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

601

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Cetuximab
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Accelerated Community Oncology Research Network